Ignite Creation Date:
2025-12-25 @ 12:52 AM
Ignite Modification Date:
2025-12-25 @ 11:07 PM
Study NCT ID:
NCT05269667
Status:
TERMINATED
Last Update Posted:
2025-01-22
First Post:
2022-02-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-26
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-15
First Submit QC Date:
None
Study First Post Date:
2022-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-18
Results First Submit QC Date:
None
Results First Post Date:
2025-01-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-20
Last Update Post Date:
2025-01-22
Last Update Post Date Type:
ACTUAL